Intervention of the President of the Government during the visit to the Rovi laboratories.

Spain Pedro Sánchez · Prime Minister of Spain

14 May 2021 · Visit to the Rovi laboratories · Rovi laboratories, Granada, Spain

Context
Sánchez visited Rovi laboratories in Granada in May 2021 to highlight Spain's vaccination progress and the importance of domestic pharmaceutical strategic autonomy.
Main themes
COVID-19 vaccination progress, strategic autonomy in pharmaceutical production, Spain's National Health System capacity, European Union vaccination goals, collaboration with autonomous communities, pharmaceutical industry innovation, quality employment, territorial cohesion, pandemic recovery
Duration
~11 min
40th percentile
Words
1,365
40th percentile
Sentences
46
30th percentile
Readability
33
21st percentile
Grade
16.1
84th percentile
Syntax
3.26
79th percentile
Vocabulary
2.09
24th percentile

Translated from Spanish

Content
Actors
Style

The broad sphere of national life a sentence belongs to. Every sentence has an Arena, so it is the denominator the other indices are read against.

Other
  • Social 30%30%
  • Economic 26%26%
  • Ceremonial 22%22%
  • Geopolitical 20%20%
  • Institutional 2%2%
  • Technological 0%0%
  • Environmental 0%0%
  • Not in focus 0%

46 sentences in 29 paragraphs

Thank you very much.

First of all, I would like to thank the Rovi company again, the Rovi family; we had the opportunity to meet many months ago at their headquarters in San Sebastián de los Reyes, in the Community of Madrid, and now we are here in Granada, in Andalusia.

First, I want to thank you for this visit and thank the Rovi family for their hospitality.

Secondly, I would also like to thank the presence of the Minister of Health of the Junta de Andalucía, with whom we are working extraordinarily well, as we are with all the autonomous communities. We have always said, since the beginning of the pandemic, that our fight is against COVID-19 and therefore, for overcoming this pandemic, and in that sense, I want to emphasize the very positive collaboration we are having with the autonomous communities, from the Ministry of Health and particularly with the Junta de Andalucía.

Thirdly, I want to thank the presence of the other institutions, the Delegation, the Government, the Provincial Council, and undoubtedly also the mayor of Granada, who I imagine must be very proud to have an industry of this power and these characteristics in Granada.

I would like to make three reflections, three references, in addition to the thanks and the pride that I logically feel as the President of the Government to be able to see a family business, with a lot of tradition in the pharmaceutical field, but led by young people, also with many female workers, something that is always appreciated.

I would like to convey three reflections.

The first of these is about vaccination. I think I mentioned it yesterday when we made an announcement; vaccination is leading us straight to herd immunity, to achieving that common goal that the entire European Union has of vaccinating 70 percent of the European population and also 70 percent of the Spanish population before the end of summer, reaching those 33 million compatriots vaccinated before the end of summer.

We are moving straight towards that process of immunity for the entire Spanish society. The data is there; we are at the forefront, we are leading along with other countries in the vaccination process at the European level. We have already supplied or administered, to be more precise, 21 million doses to the entire Spanish population.

The level of immunity and reaching 100 percent of people over 80 years old, over 70 years old is very close, if not already achieved. More than 6 million compatriots have the complete vaccination schedule.

And a very significant figure that demonstrates the capacity of the National Health System and above all the professionalism of our healthcare workers is that from March 12 to May 12, we have administered over 15 million doses of the COVID vaccine to Spaniards.

And this figure of 15 million doses is very important because it is the same number of doses that were also administered in a very similar timeframe, one week more, when we talk about the flu vaccination last year. Therefore, what I want to say with this is that we are demonstrating not only a commitment and extraordinary professionalism of the National Health System, but also an acceptance of the vaccine by the Spanish population, I believe that we are at the forefront with a very high percentage compared to other European countries, and therefore, I think we must continue to reaffirm that commitment to achieve 70 percent herd immunity before the end of summer.

Secondly, I believe that we Spaniards increasingly need to understand what the concept of strategic autonomy means. We all remember at the beginning of the pandemic how we had to look to Asia to obtain many of the materials that protected us first in hospitals for healthcare professionals, and later, for us, the entire population with masks. Well, I think the example of Rovi and other pharmaceutical companies in our country demonstrates the importance of not only Spain but Europe having strategic autonomy.

What does strategic autonomy mean? It means security. That is, when we suffer potential pandemics that will come in the future, hopefully many years from now and of the magnitude that we are currently experiencing with the COVID-19 pandemic, we have the necessary protection to guarantee the safety and lives of our fellow citizens.

Secondly, it means quality employment, and we are seeing that here in this company as well.

And thirdly, it means innovation, economic growth, it means ultimately, development. And furthermore, in this sense, a development that also represents territorial cohesion. That is, we are not all concentrated in a single province of our country, but we expand that territorial vision of what economic development represents to the entire country.

Therefore, strategic autonomy is a fundamental challenge that represents security, industrialization, innovation, and quality employment. And this is something that is being worked on not only in Spain but also in Europe for months now, and I must say it is also under the leadership of Spain.

And finally, the last element I would like to convey is that of public-private collaboration. On many occasions, we have said that one of the great successes of this calamity represented by COVID-19 has been the unity of all, the unity of course of the member countries that through the European Commission have advanced resources to pharmaceutical companies to accelerate the entire process of innovation, research, and therefore, the materialization of the vaccine, the scientific remedy to the pandemic, and also the purchase of the same that guaranteed equity in access, regardless of the economic resources that each citizen had throughout the European territory.

And I find this fundamental because it represents a turning point in the process of European construction, guaranteeing the health security of all European citizens.

That unity, I believe, is very significant, not only from the perspective of the member states, not only from the point of view of the institutional architecture that represents our country, but this is what I want to reach: public-private collaboration.

I believe that one of the great lessons we must draw from this pandemic is that together we are stronger when the private sector and the public sector work hand in hand.

Earlier, when I had the opportunity and the honor to visit some of the laboratories of the Rovi company, I realized many of the projects funded with European public resources through, significantly, the CDTI, which is one of the main instruments we have at the Spanish level.

Well, I believe this is one of the lessons we must draw from the pandemic. There are many investments, many research projects that need the support and advance of resources from public investment, that is, from the public sector. And in that sense, I would like to convey that we believe in this public-private collaboration, that we believe in the alliance between the public and the private, and that certainly if something has been made visible in this pandemic, it is that indeed, together we are stronger and make our societies safer.

Therefore, vaccination is leading us straight to herd immunity. What we must do is not let our guard down; the virus is still circulating among us, and therefore, masks, distance, well, hand washing, everything we know we must continue to apply, but we are taking a very significant step towards achieving that herd immunity.

Secondly, unity, the unity of all.

And thirdly, strategic autonomy, which is industry, which is employment, and which is security against future health emergencies.

And again, thank you very much to the Junta de Andalucía.

Thank you very much to the Government Delegation, to the Provincial Council, to the city of Granada, and undoubtedly to the protagonists who are the workers and management of Rovi, because it is a source of pride as the President of the Government to see companies committed to Spain, to their territories, not only to one but to many territories, and undoubtedly I foresee that we have many years of fruitful collaboration ahead between the Government of Spain and public institutions and your company, as well as many other pharmaceutical companies that fortunately are in our country.

Thank you.